Adds Proprietary Multiplexed In Vivo and Tissue Imaging Technology to Caliper’s Leading Portfolio of Drug Discovery, Imaging and Diagnostics Solutions HOPKINTON and WOBURN, Mass. – Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of products and services for drug discovery research, today announced that it has entered into a definitive agreement to acquire privately-held […]
A team of UCSF researchers has engineered E. coli with the key molecular circuitry that will enable genetic engineers to program cells to communicate and perform computations. The work builds into cells the same logic gates found in electronic computers and creates a method to create circuits by “rewiring” communications between cells. This system can […]
San Francisco, US – Panasonic, core partner within imec’s Human++ program and imec today present at the International Electron Devices Meeting in San Francisco various critical components of a biomedical lab-on-chip sensor enabling fast detection of Single Nucleotide Polymorphisms (SNPs) in DNA, such as a miniaturized pump for on-chip generation of high pressures, a micropillar […]
Anticipated EPA Revenues Confirmed; Bolsters Caliper’s 2010 Revenue Outlook HOPKINTON, Mass. – Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today announced that the company has received the remaining balance of the compound library for the Environmental Protection Agency’s (EPA) Phase II ToxCast(TM) […]
Company Intends to Commercialize In Vitro Diagnostic Products on its nCounter Platform SEATTLE, Wash. – NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced it has secured an exclusive worldwide license from Bioclassifier, LLC to develop in […]
SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of Fluidigm’s common stock. Fluidigm develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or […]
SAN DIEGO – Sequenom, Inc. (Nasdaq: SQNM) today announced the pricing of an underwritten public offering of 14,000,000 shares of its common stock, offered at a price to the public of $6.00 per share. The gross proceeds to Sequenom from this offering are expected to be $84.0 million, before deducting underwriting discounts and commissions and […]
CAMBRIDGE, MA – Quanterix Corporation announced today that Martin D. Madaus, Ph.D has joined the company’s Board as Executive Chairman. Dr. Madaus brings more than 20 years of experience in the diagnostics and life science industries, most recently serving as President, Chairman and CEO of Millipore Corporation, recently acquired by Merck KGaA. “Martin brings significant […]
Qubit(R) 2.0 Fluorometer Designed for Use with Precious Samples, Applications Requiring Large Financial and Time Investment CARLSBAD, Calif. – Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced the launch of its next-generation Qubit(R) 2.0 Fluorometer specifically for molecular biology researchers who work with precious samples and perform applications that […]
PrecisionCells.com, a manufacturer and designer of quality cuvettes, offers custom manufacturing services of quartz optical products. PrecisionCells.com, the leading manufacturer and designer of high quality cuvettes, offers custom manufacturing services of quartz optical products. Being one of the few companies that can custom manufacturer quartz optical components, PrecisionCells.com offers a wide range of quartz cuvettes, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
